| 1465-6566 |
EXPERT OPINION ON PHARMACOTHERAPY |
MEDICINA III |
A3 |
2017-2020 |
| 1465-6566 |
EXPERT OPINION ON PHARMACOTHERAPY |
CIÊNCIAS BIOLÓGICAS II |
A3 |
2017-2020 |
| 1465-6566 |
EXPERT OPINION ON PHARMACOTHERAPY |
CIÊNCIAS BIOLÓGICAS I |
A3 |
2017-2020 |
| 1465-6566 |
EXPERT OPINION ON PHARMACOTHERAPY |
INTERDISCIPLINAR |
A3 |
2017-2020 |
| 2167-8707 |
EXPERT OPINION ON ORPHAN DRUGS |
MEDICINA II |
A3 |
2017-2020 |
| 2167-8707 |
EXPERT OPINION ON ORPHAN DRUGS |
MEDICINA III |
A3 |
2017-2020 |
| 2167-8707 |
EXPERT OPINION ON ORPHAN DRUGS |
MEDICINA I |
A3 |
2017-2020 |
| 2167-8707 |
EXPERT OPINION ON ORPHAN DRUGS |
SAÚDE COLETIVA |
A3 |
2017-2020 |
| 2167-8707 |
EXPERT OPINION ON ORPHAN DRUGS |
CIÊNCIAS BIOLÓGICAS I |
A3 |
2017-2020 |
| 2167-8707 |
EXPERT OPINION ON ORPHAN DRUGS |
CIÊNCIAS BIOLÓGICAS II |
A3 |
2017-2020 |
| 1354-3784 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
CIÊNCIAS BIOLÓGICAS I |
A1 |
2017-2020 |
| 1354-3784 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
CIÊNCIAS BIOLÓGICAS II |
A1 |
2017-2020 |
| 1354-3784 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
MEDICINA I |
A1 |
2017-2020 |
| 1354-3784 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
MEDICINA II |
A1 |
2017-2020 |
| 1474-0338 |
EXPERT OPINION ON DRUG SAFETY |
MEDICINA I |
A2 |
2017-2020 |